[Potential cardiotonics. 9. Synthesis and cardiovascular effects of 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- and 2-hetarylamino-substituted 3-cyan-5-(pyrid-4-yl)-pyridines].
Roloff
B
B
Institut für Wirkstofforschung, Akademie der Wissenschaften der DDR, Berlin.
Schäfer
J
J
Rumler
A
A
Hagen
V
V
Hagen
A
A
D000818:Animals; D002316:Cardiotonic Agents / Q000138:chemical synthesis*; D055598:Chemical Phenomena; D002621:Chemistry; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D066298:In Vitro Techniques; D009682:Magnetic Resonance Spectroscopy; D008744:Methylamines / Q000138:chemical synthesis / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects; D009570:Nitriles / Q000138:chemical synthesis* / Q000494:pharmacology; D011720:Pyrazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D011725:Pyridines / Q000138:chemical synthesis* / Q000494:pharmacology
D002316:Cardiotonic Agents; D008744:Methylamines; D009570:Nitriles; D011720:Pyrazoles; D011725:Pyridines
Potentielle Kardiotonika. 9. Mitteilung4: Synthese und kardiovaskuläre Eigenschaften von 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- und 2-hetarylamino-substituierten 3-Cyan-5-(pyrid-4-yl)-pyridinen.